{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T10:44:49Z","timestamp":1788173089460,"version":"build-2803163510"},"reference-count":71,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI095190"],"award-info":[{"award-number":["AI095190"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI123371"],"award-info":[{"award-number":["AI123371"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012443","name":"Maryland Stem Cell Research Fund","doi-asserted-by":"publisher","award":["#2018-MSCRFD-4246"],"award-info":[{"award-number":["#2018-MSCRFD-4246"]}],"id":[{"id":"10.13039\/100012443","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Children's Gaucher Research Fund","award":["2021"],"award-info":[{"award-number":["2021"]}]},{"name":"National Center for Advancing Translational Sciences (NCATS) Clinical Translational Science Award (CTSA)","award":["1UL1TR003098"],"award-info":[{"award-number":["1UL1TR003098"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Gaucher disease (GD) is an autosomal recessive disorder caused by bi-allelic GBA1 mutations that reduce the activity of the lysosomal enzyme \u03b2-glucocerebrosidase (GCase). GCase catalyzes the conversion of glucosylceramide (GluCer), a ubiquitous glycosphingolipid, to glucose and ceramide. GCase deficiency causes the accumulation of GluCer and its metabolite glucosylsphingosine (GluSph) in a number of tissues and organs. In the immune system, GCase deficiency deregulates signal transduction events, resulting in an inflammatory environment. It is known that the complement system promotes inflammation, and complement inhibitors are currently being considered as a novel therapy for GD; however, the mechanism by which complement drives systemic macrophage-mediated inflammation remains incompletely understood. To help understand the mechanisms involved, we used human GD-induced pluripotent stem cell (iPSC)-derived macrophages. We found that GD macrophages exhibit exacerbated production of inflammatory cytokines via an innate immune response mediated by receptor 1 for complement component C5a (C5aR1). Quantitative RT-PCR and ELISA assays showed that in the presence of recombinant C5a (rC5a), GD macrophages secreted 8\u201310-fold higher levels of TNF-\u03b1 compared to rC5a-stimulated control macrophages. PMX53, a C5aR1 blocker, reversed the enhanced GD macrophage TNF-\u03b1 production, indicating that the observed effect was predominantly C5aR1-mediated. To further analyze the extent of changes induced by rC5a stimulation, we performed gene array analysis of the rC5a-treated macrophage transcriptomes. We found that rC5a-stimulated GD macrophages exhibit increased expression of genes involved in TNF-\u03b1 inflammatory responses compared to rC5a-stimulated controls. Our results suggest that rC5a-induced inflammation in GD macrophages activates a unique immune response, supporting the potential use of inhibitors of the C5a-C5aR1 receptor axis to mitigate the chronic inflammatory abnormalities associated with GD.<\/jats:p>","DOI":"10.3390\/ijms22189912","type":"journal-article","created":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T21:47:21Z","timestamp":1631656041000},"page":"9912","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages"],"prefix":"10.3390","volume":"22","author":[{"given":"Jacquelyn C.","family":"Serfecz","sequence":"first","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsoon","family":"Saadin","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clayton P.","family":"Santiago","sequence":"additional","affiliation":[{"name":"The Solomon H. Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren M.","family":"Bentzen","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Public Health, University of Maryland, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8244-2555","authenticated-orcid":false,"given":"Stefanie N.","family":"Vogel","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo A.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,9,14]]},"reference":[{"key":"ref_1","unstructured":"National Human Genome Research Institute (2014, April 04). About Gaucher Disease, Available online: http:\/\/www.genome.gov\/25521505."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Stirnemann, J., Belmatoug, N., Camou, F., Serratrice, C., Froissart, R., Caillaud, C., Levade, T., Astudillo, L., Serratrice, J., and Brassier, A. (2017). A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020441"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Sheth, J., Bhavsar, R., Mistri, M., Pancholi, D., Bavdekar, A., Dalal, A., Ranganath, P., Girisha, K.M., Shukla, A., and Phadke, S. (2019). Gaucher disease: Single gene molecular characterization of one-hundred Indian patients reveals novel variants and the most prevalent mutation. BMC Med. Genet., 20.","DOI":"10.1186\/s12881-019-0759-1"},{"key":"ref_4","unstructured":"Stenson, P.D. (2020). The Human Gene Mutation Database (HGMD). Hum. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/B978-0-444-59565-2.00040-X","article-title":"Gaucher disease","volume":"113","author":"Mignot","year":"2013","journal-title":"Handb. Clin. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"192761","DOI":"10.1155\/2015\/192761","article-title":"Pathogenesis of Bone Alterations in Gaucher Disease: The Role of Immune System","volume":"2015","author":"Mucci","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0609.1985.tb02269.x","article-title":"Association of Gaucher\u2019s disease and lymphoid malignancy in 2 children","volume":"35","author":"Burstein","year":"1985","journal-title":"Scand. J. Haematol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1258\/smj.2011.011178","article-title":"Synchronous presentation of Gaucher disease and solitary plasmacytoma with progression to multiple myeloma","volume":"56","author":"Hawkesford","year":"2011","journal-title":"Scott. Med. J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bcmd.2005.08.004","article-title":"Increased incidence of cancer in adult Gaucher disease in Western Europe","volume":"36","author":"Weverling","year":"2006","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_10","first-page":"388","article-title":"Gaucher\u2019s disease: A disease with chronic stimulation of the immune system","volume":"106","author":"Shoenfeld","year":"1982","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.1182\/blood-2004-12-4672","article-title":"Gaucher disease and cancer incidence: A study from the Gaucher Registry","volume":"105","author":"Rosenbloom","year":"2005","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/sctm.20-0302","article-title":"Synthetic mRNA-based differentiation method enables early detection of Parkinson\u2019s phenotypes in neurons derived from Gaucher disease-induced pluripotent stem cells","volume":"10","author":"Akiyama","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/sctm.20-0386","article-title":"Elevated glucosylsphingosine in Gaucher disease induced pluripotent stem cell neurons deregulates lysosomal compartment through mammalian target of rapamycin complex 1","volume":"10","author":"Srikanth","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1615\/CritRevOncog.2013006060","article-title":"Gaucher disease: A comprehensive review","volume":"18","author":"Rosenbloom","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"ref_15","unstructured":"(2020, August 18). National Library of Medicine: National Institutes of Health. Genetics Home Reference: Gaucher Disease, Available online: http:\/\/ghr.nlm.nih.gov\/condition\/gaucher-disease."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/stem.1732","article-title":"Gaucher iPSC-derived macrophages produce elevated levels of inflammatory mediators and serve as a new platform for therapeutic development","volume":"32","author":"Panicker","year":"2014","journal-title":"Stem Cells"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jcp.21023","article-title":"Altered intracellular redox status in Gaucher disease fibroblasts and impairment of adaptive response against oxidative stress","volume":"212","author":"Deganuto","year":"2007","journal-title":"J. Cell. Physiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"6060","DOI":"10.1038\/s41598-019-42584-1","article-title":"Gene expression profile in patients with Gaucher disease indicates activation of inflammatory processes","volume":"9","author":"Lugowska","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1310\/hpj5107-553","article-title":"Enzyme Replacement or Substrate Reduction? A Review of Gaucher Disease Treatment Options","volume":"51","author":"Holsopple","year":"2016","journal-title":"Hosp. Pharm."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1615\/CritRevOncog.2013006145","article-title":"Gaucher disease and malignancy: A model for cancer pathogenesis in an inborn error of metabolism","volume":"18","author":"Mistry","year":"2013","journal-title":"Crit. Rev. Oncog."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Dubot, P., Astudillo, L., Therville, N., Sabourdy, F., Stirnemann, J., Levade, T., and Andrieu-Abadie, N. (2020). Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses. Cancers, 12.","DOI":"10.3390\/cancers12020475"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Limgala, R.P., and Goker-Alpan, O. (2020). Effect of Substrate Reduction Therapy in Comparison to Enzyme Replacement Therapy on Immune Aspects and Bone Involvement in Gaucher Disease. Biomolecules, 10.","DOI":"10.3390\/biom10040526"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s10545-018-0142-y","article-title":"Hepatocellular carcinoma in Gaucher disease: An international case series","volume":"41","author":"Regenboog","year":"2018","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/ajh.21362","article-title":"The underrecognized progressive nature of N370S Gaucher disease and assessment of cancer risk in 403 patients","volume":"84","author":"Taddei","year":"2009","journal-title":"Am. J. Hematol."},{"key":"ref_26","first-page":"100564","article-title":"Liver involvement in patients with Gaucher disease types I and III","volume":"22","author":"Starosta","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41232-016-0013-6","article-title":"Complement-targeted therapy: Development of C5- and C5a-targeted inhibition","volume":"36","author":"Horiuchi","year":"2016","journal-title":"Inflamm. Regen."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e98259","DOI":"10.1172\/jci.insight.98259","article-title":"Antigen-mediated regulation in monoclonal gammopathies and myeloma","volume":"3","author":"Nair","year":"2018","journal-title":"JCI Insight"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal Immunoglobulin against Lysolipids in the Origin of Myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.3389\/fimmu.2019.01143","article-title":"Beta-Glycosphingolipids as Mediators of Both Inflammation and Immune Tolerance: A Manifestation of Randomness in Biological Systems","volume":"10","author":"Ilan","year":"2019","journal-title":"Front. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1042\/EBC20190090","article-title":"Lyso-glycosphingolipids: Presence and consequences","volume":"64","author":"Ferraz","year":"2020","journal-title":"Essays Biochem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/s12276-020-0384-2","article-title":"ROS in cancer therapy: The bright side of the moon","volume":"52","author":"Perillo","year":"2020","journal-title":"Exp. Mol. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: Links to genetic instability","volume":"30","author":"Colotta","year":"2009","journal-title":"Carcinogenesis"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"13229","DOI":"10.18632\/oncotarget.3644","article-title":"Massive parallel IGHV gene sequencing reveals a germinal center pathway in origins of human multiple myeloma","volume":"6","author":"Cowan","year":"2015","journal-title":"Oncotarget"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0140-6736(94)92832-0","article-title":"Oxy-radicals and cancer","volume":"344","author":"Cerutti","year":"1994","journal-title":"Lancet"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood.V76.4.655.655","article-title":"Inflammation and cancer: Role of phagocyte-generated oxidants in carcinogenesis","volume":"76","author":"Weitzman","year":"1990","journal-title":"Blood"},{"key":"ref_37","first-page":"913","article-title":"Enhancement of cancer invasion and growth via the C5a-C5a receptor system: Implications for cancer promotion by autoimmune diseases and association with cervical cancer invasion","volume":"17","author":"Yoneda","year":"2019","journal-title":"Oncol. Lett."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ccell.2018.09.003","article-title":"Complement C5a Fosters Squamous Carcinogenesis and Limits T Cell Response to Chemotherapy","volume":"34","author":"Medler","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12935-019-1027-3","article-title":"Role of the complement system in the tumor microenvironment","volume":"19","author":"Zhang","year":"2019","journal-title":"Cancer Cell Int."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1172\/JCI0214530","article-title":"Systemic inflammation in glucocerebrosidase-deficient mice with minimal glucosylceramide storage","volume":"109","author":"Mizukami","year":"2002","journal-title":"J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1086\/427188","article-title":"Inhibition of p38 mitogen-activated protein kinase ameliorates cytokine up-regulated shigatoxin-1 toxicity in human brain microvascular endothelial cells","volume":"191","author":"Stricklett","year":"2005","journal-title":"J. Infect. Dis."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.3389\/fimmu.2020.01789","article-title":"Complement C5a Induces Pro-inflammatory Microvesicle Shedding in Severely Injured Patients","volume":"11","author":"Karasu","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s12974-020-01934-x","article-title":"Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease","volume":"17","author":"Vardi","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"ref_44","first-page":"100667","article-title":"Patients with Gaucher disease display systemic oxidative stress dependent on therapy status","volume":"25","author":"Kartha","year":"2020","journal-title":"Mol. Genet. Metab. Rep."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"10903","DOI":"10.1038\/srep10903","article-title":"Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant beta-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease","volume":"5","author":"Cotan","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_46","unstructured":"(2018). Database resources of the National Center for Biotechnology Information. Nucleic Acids Res., 46, D8\u2013D13."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1042\/BST0350284","article-title":"Oxidative stress and macrophage function: A failure to resolve the inflammatory response","volume":"35","author":"Kirkham","year":"2007","journal-title":"Biochem. Soc. Trans."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/qjmed\/93.4.237","article-title":"Massive hepatic fibrosis in Gaucher\u2019s disease: Clinico-pathological and radiological features","volume":"93","author":"Lachmann","year":"2000","journal-title":"QJM"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Bohte, A.E., van Dussen, L., Akkerman, E.M., Nederveen, A.J., Sinkus, R., Jansen, P.L., Stoker, J., and Hollak, C.E. (2013). Liver fibrosis in type I Gaucher disease: Magnetic resonance imaging, transient elastography and parameters of iron storage. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057507"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.lfs.2013.12.024","article-title":"The profibrotic role of endothelin-1: Is the door still open for the treatment of fibrotic diseases?","volume":"118","author":"Busnadiego","year":"2014","journal-title":"Life Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.gene.2008.05.022","article-title":"Spontaneous hepatic fibrosis in transgenic mice overexpressing PDGF-A","volume":"423","author":"Thieringer","year":"2008","journal-title":"Gene"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s41598-017-00377-4","article-title":"Enhanced Wnt Signalling in Hepatocytes is Associated with Schistosoma japonicum Infection and Contributes to Liver Fibrosis","volume":"7","author":"Wang","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41423-020-00558-8","article-title":"Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities","volume":"18","author":"Wen","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Lu, J.W., Liao, C.Y., Yang, W.Y., Lin, Y.M., Jin, S.L., Wang, H.D., and Yuh, C.H. (2014). Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0085318"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1615\/CritRevEukarGeneExpr.v20.i2.10","article-title":"Tumor necrosis factor-alpha signaling in macrophages","volume":"20","author":"Parameswaran","year":"2010","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"5409","DOI":"10.1073\/pnas.1916897117","article-title":"Interferon lambda promotes immune dysregulation and tissue inflammation in TLR7-induced lupus","volume":"117","author":"Goel","year":"2020","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.immuni.2015.01.020","article-title":"Emerging functions of amphiregulin in orchestrating immunity, inflammation, and tissue repair","volume":"42","author":"Zaiss","year":"2015","journal-title":"Immunity"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1603131","DOI":"10.1155\/2019\/1603131","article-title":"Amphiregulin Regulates Phagocytosis-Induced Cell Death in Monocytes via EGFR and the Bcl-2 Protein Family","volume":"2019","author":"Platen","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41589-018-0213-2","article-title":"IFITM3 directly engages and shuttles incoming virus particles to lysosomes","volume":"15","author":"Spence","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41586-020-2884-6","article-title":"IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells","volume":"588","author":"Lee","year":"2020","journal-title":"Nature"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Kitatani, K., Wada, M., Perry, D., Usui, T., Sun, Y., Obeid, L.M., Yaegashi, N., Grabowski, G.A., and Hannun, Y.A. (2015). Activation of p38 Mitogen-Activated Protein Kinase in Gaucher\u2019s Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0136633"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/acel.12409","article-title":"Lysosomal storage and impaired autophagy lead to inflammasome activation in Gaucher macrophages","volume":"15","author":"Aflaki","year":"2016","journal-title":"Aging Cell"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1007\/s10753-014-9971-5","article-title":"MAPK and NF-kappaB pathways are involved in bisphenol A-induced TNF-alpha and IL-6 production in BV2 microglial cells","volume":"38","author":"Zhu","year":"2015","journal-title":"Inflammation"},{"key":"ref_64","unstructured":"Binder, M.D., Hirokawa, N., and Windhorst, U. (2009). Neurodegenerative Diseases\u2013MAPK Signalling Pathways in Neuroinflammation. Encyclopedia of Neuroscience, Springer."},{"key":"ref_65","first-page":"216298","article-title":"Transcriptional Factor NF-kappaB as a Target for Therapy in Parkinson\u2019s Disease","volume":"2011","author":"Flood","year":"2011","journal-title":"Parkinson Dis."},{"key":"ref_66","first-page":"155","article-title":"Cross-Regulation Between Wnt and NF-kappaB Signaling Pathways","volume":"1","author":"Du","year":"2010","journal-title":"Onco Ther."},{"key":"ref_67","first-page":"7031","article-title":"Neuronopathic Gaucher disease: Dysregulated mRNAs and miRNAs in brain pathogenesis and effects of pharmacologic chaperone treatment in a mouse model","volume":"24","author":"Dasgupta","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/j.stemcr.2017.10.029","article-title":"Altered Differentiation Potential of Gaucher\u2019s Disease iPSC Neuronal Progenitors due to Wnt\/beta-Catenin Downregulation","volume":"9","author":"Awad","year":"2017","journal-title":"Stem Cell Rep."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/hmg\/ddz293","article-title":"A transcriptional and post-transcriptional dysregulation of Dishevelled 1 and 2 underlies the Wnt signaling impairment in type I Gaucher disease experimental models","volume":"29","author":"Costa","year":"2020","journal-title":"Hum. Mol. Genet."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"18054","DOI":"10.1073\/pnas.1207889109","article-title":"Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease","volume":"109","author":"Panicker","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/0471142735.im1427s95","article-title":"Measuring opsonic phagocytosis via Fcgamma receptors and complement receptors on macrophages","volume":"95","author":"Mosser","year":"2011","journal-title":"Curr. Protoc. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/18\/9912\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:02:24Z","timestamp":1760166144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/18\/9912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":71,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,9]]}},"alternative-id":["ijms22189912"],"URL":"https:\/\/doi.org\/10.3390\/ijms22189912","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,14]]}}}